BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALTUV - FR0013345493 - Common Stock
1.562 EUR
-0.01 (-0.51%)
ALTUV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. ALTUV has only an average score on both its financial health and profitability. ALTUV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ALTUV had positive earnings in the past year.
In the past year ALTUV had a positive cash flow from operations.
ALTUV had positive earnings in each of the past 5 years.
Of the past 5 years ALTUV 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ALTUV (1.36%) is worse than 65.14% of its industry peers.
ALTUV's Return On Equity of 2.41% is on the low side compared to the rest of the industry. ALTUV is outperformed by 66.97% of its industry peers.
With a Return On Invested Capital value of 2.84%, ALTUV is not doing good in the industry: 70.64% of the companies in the same industry are doing better.
ALTUV had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 8.88%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROIC | 2.84% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
1.3 Margins
ALTUV has a Profit Margin (2.64%) which is comparable to the rest of the industry.
ALTUV's Profit Margin has declined in the last couple of years.
The Operating Margin of ALTUV (5.93%) is comparable to the rest of the industry.
ALTUV's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 38.14%, ALTUV perfoms like the industry average, outperforming 48.62% of the companies in the same industry.
In the last couple of years the Gross Margin of ALTUV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% |
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALTUV is destroying value.
The number of shares outstanding for ALTUV has been reduced compared to 1 year ago.
The number of shares outstanding for ALTUV has been increased compared to 5 years ago.
Compared to 1 year ago, ALTUV has an improved debt to assets ratio.
2.2 Solvency
ALTUV has an Altman-Z score of 1.45. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.45, ALTUV is doing worse than 65.14% of the companies in the same industry.
ALTUV has a debt to FCF ratio of 7.69. This is a slightly negative value and a sign of low solvency as ALTUV would need 7.69 years to pay back of all of its debts.
The Debt to FCF ratio of ALTUV (7.69) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.39 indicates that ALTUV is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.39, ALTUV perfoms like the industry average, outperforming 48.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Altman-Z | 1.45 |
ROIC/WACC0.39
WACC7.22%
2.3 Liquidity
A Current Ratio of 2.05 indicates that ALTUV has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.05, ALTUV is doing good in the industry, outperforming 77.98% of the companies in the same industry.
ALTUV has a Quick Ratio of 1.31. This is a normal value and indicates that ALTUV is financially healthy and should not expect problems in meeting its short term obligations.
ALTUV's Quick ratio of 1.31 is fine compared to the rest of the industry. ALTUV outperforms 72.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 195.24% over the past year.
The earnings per share for ALTUV have been decreasing by -64.42% on average. This is quite bad
Looking at the last year, ALTUV shows a decrease in Revenue. The Revenue has decreased by -7.99% in the last year.
ALTUV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.65% yearly.
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
3.2 Future
ALTUV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.51% yearly.
Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 22.31, which indicates a rather expensive current valuation of ALTUV.
ALTUV's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.34. ALTUV is around the same levels.
ALTUV is valuated correctly with a Price/Forward Earnings ratio of 15.17.
The rest of the industry has a similar Price/Forward Earnings ratio as ALTUV.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.56, ALTUV is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.31 | ||
| Fwd PE | 15.17 |
4.2 Price Multiples
61.47% of the companies in the same industry are more expensive than ALTUV, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALTUV is valued cheaply inside the industry as 81.65% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.05 | ||
| EV/EBITDA | 9.1 |
4.3 Compensation for Growth
A more expensive valuation may be justified as ALTUV's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3Y14.51%
5. Dividend
5.1 Amount
ALTUV has a Yearly Dividend Yield of 2.50%.
ALTUV's Dividend Yield is a higher than the industry average which is at 2.37.
ALTUV's Dividend Yield is comparable with the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPA:ALTUV (12/8/2025, 7:00:00 PM)
1.562
-0.01 (-0.51%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners5.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.10M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target3.06 (95.9%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.31 | ||
| Fwd PE | 15.17 | ||
| P/S | 0.58 | ||
| P/FCF | 8.05 | ||
| P/OCF | 4.64 | ||
| P/B | 0.53 | ||
| P/tB | 4.31 | ||
| EV/EBITDA | 9.1 |
EPS(TTM)0.07
EY4.48%
EPS(NY)0.1
Fwd EY6.59%
FCF(TTM)0.19
FCFY12.43%
OCF(TTM)0.34
OCFY21.57%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.41% | ||
| ROCE | 3.87% | ||
| ROIC | 2.84% | ||
| ROICexc | 2.84% | ||
| ROICexgc | 7.55% | ||
| OM | 5.93% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% | ||
| FCFM | 7.26% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.69 | ||
| Debt/EBITDA | 3.38 | ||
| Cap/Depr | 79.6% | ||
| Cap/Sales | 5.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 99.7% | ||
| Profit Quality | 275.52% | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z | 1.45 |
F-Score7
WACC7.22%
ROIC/WACC0.39
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)195.24%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A
BIO-UV GROUP SAS / ALTUV.PA FAQ
Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?
ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.
What is the valuation status for ALTUV stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.
What is the profitability of ALTUV stock?
BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.
How financially healthy is BIO-UV GROUP SAS?
The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.
What is the earnings growth outlook for BIO-UV GROUP SAS?
The Earnings per Share (EPS) of BIO-UV GROUP SAS (ALTUV.PA) is expected to decline by -29.92% in the next year.